热门资讯> 正文
京和麒麟宣布管理层变动
2025-12-11 16:12
- Kyowa Kirin (KYKOF) (KNBWY) appointed Abdul Mullick, Ph.D., as President and CEO effective March 2026.
- This follows a dual CEO/COO leadership model implemented in March 2025, where Mullick served as COO alongside Masashi Miyamoto, Ph.D., marking a transition to the company's first non-Japanese CEO.
- Masashi Miyamoto will transition to Chairman while remaining involved in strategic oversight.
- In his new role as CEO, Mullick will focus on driving execution of the company’s Vision for 2030 in the focus disease areas of Bone/Mineral, Intractable Haematological Diseases/Haemato-Oncology and Rare Diseases.
- Mullick joined the company in 2017 and served as President of the Europe / Middle East / Africa region, based in Marlow, United Kingdom, before relocating to Japan in 2023 to lead the business outside of Japan.
More on Kyowa Kirin Co., Ltd.
- Kura Oncology wins FDA approval for leukemia drug
- Seeking Alpha’s Quant Rating on Kyowa Kirin Co., Ltd.
- Historical earnings data for Kyowa Kirin Co., Ltd.
- Dividend scorecard for Kyowa Kirin Co., Ltd.
- Financial information for Kyowa Kirin Co., Ltd.
推荐文章
一周财经日历 | 美联储新主席“呼之欲出”！特朗普下周或提前公布；年末新股上市潮！卧安机器人、英矽智能等6只新股招股中
年终盘点 | 26年投资展望！美股有哪些经济大事？
年终盘点 | 2025年港美股十大飙升ETF：年内暴涨620%！Palantir多头杠杆ETF成年度黑马
年终盘点 | 2025年港股牛股、妖股、熊股名单出炉！这家公司飙升超33倍后跌落神坛
华盛早报 | 科技股强劲反弹！纳指一度涨超2%；哈塞特称仍有很大的降息空间
年终盘点 | 美股七巨头从“集体狂飙”到“残酷分化”！谁能在2026年继续坐庄？
打新攻略 | 2025港股IPO收官战！6只招股+9只待上市+6只聆讯！打新资金如何巧妙“吃大肉”？
年末货币政策“压轴大戏”：欧洲四央行同日登场，仅一家有望降息？
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
